Skip to content
Dx

HCPCS Level II · Temporary national codes (non-Medicare)

S2107Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About S2107

S2107 is an HCPCS Level II code in the S series (temporary national codes (non-Medicare)), describing adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment.

It was added to HCPCS effective 04/01/2002.

Its Medicare coverage code is "I", meaning it is not payable by Medicare (another code or method is used).

Details

Short description
Adoptive immunotherapy
Date added
04/01/2002
Action effective
04/01/2002
BETOS
Z2

Related S21xx codes

Common questions about S2107

Is HCPCS S2107 still valid?

Yes. S2107 is active in the CMS October 2026 HCPCS file.

Does Medicare cover S2107?

Its coverage code is "I": it is not payable by Medicare (another code or method is used). Check the local coverage determination for your region.